| scholarly article | Q13442814 |
| P50 | author | Michael T Lawton | Q71013029 |
| Kunlin Jin | Q107353791 | ||
| P2093 | author name string | Lin Xie | |
| Ming Zhong | |||
| Yongmei Chen | |||
| Guo-Yuan Yang | |||
| William L Young | |||
| David A Greenberg | |||
| XiaoOu Mao | |||
| Qichuan ZhuGe | |||
| Gourong Chen | |||
| WeiMing Zheng | |||
| P2860 | cites work | Mutations in the human Jagged1 gene are responsible for Alagille syndrome | Q24314702 |
| Notch signaling: cell fate control and signal integration in development | Q27861061 | ||
| The Notch-Hes pathway in mammalian neural development | Q28145844 | ||
| Notch signaling: control of cell communication and cell fate | Q28245948 | ||
| Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia | Q28294011 | ||
| Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system | Q28304868 | ||
| Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants | Q28505269 | ||
| Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium | Q28506571 | ||
| Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos | Q28506962 | ||
| The Notch target genes Hey1 and Hey2 are required for embryonic vascular development | Q28586854 | ||
| HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments | Q28587806 | ||
| Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1 | Q28589104 | ||
| Notch signaling is essential for vascular morphogenesis in mice | Q29620377 | ||
| Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice | Q30483008 | ||
| Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice | Q33896087 | ||
| Notch signaling is required for arterial-venous differentiation during embryonic vascular development. | Q34093638 | ||
| Notch signaling in vascular development and physiology | Q34646081 | ||
| Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients | Q34659159 | ||
| Brain arteriovenous malformations in adults | Q36104974 | ||
| Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. | Q37594746 | ||
| Evidence of increased endothelial cell turnover in brain arteriovenous malformations | Q38460731 | ||
| Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives. | Q41078359 | ||
| Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum | Q42835101 | ||
| A secreted Delta1-Fc fusion protein functions both as an activator and inhibitor of Notch1 signaling | Q43972008 | ||
| Growth and regression of arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia | Q59152590 | ||
| Notch-mediated restoration of regenerative potential to aged muscle | Q79331504 | ||
| A garden of Notch-ly delights | Q80111418 | ||
| P433 | issue | Pt 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arteriovenous malformation | Q1584110 |
| P304 | page(s) | 3231-3241 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Notch-1 signalling is activated in brain arteriovenous malformations in humans | |
| P478 | volume | 132 |
| Q35008897 | A genome-wide investigation of copy number variation in patients with sporadic brain arteriovenous malformation |
| Q39622657 | Angiogenesis detection in cerebral arteriovenous malformations: mediators and gene expression, and treatment hopes for the future |
| Q38662338 | Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions. |
| Q41878326 | BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II. |
| Q57813960 | Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta |
| Q30301287 | Biology of cerebral arteriovenous malformations with a focus on inflammation |
| Q37897171 | Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm |
| Q53396776 | Chronic Hippocampal Expression of Notch Intracellular Domain Induces Vascular Thickening, Reduces Glucose Availability, and Exacerbates Spatial Memory Deficits in a Rat Model of Early Alzheimer. |
| Q34752162 | Constitutively active Notch4 receptor elicits brain arteriovenous malformations through enlargement of capillary-like vessels. |
| Q27302123 | Context-specific interactions between Notch and ALK1 cannot explain ALK1-associated arteriovenous malformations |
| Q30592602 | Deletion of Rbpj from postnatal endothelium leads to abnormal arteriovenous shunting in mice. |
| Q35538051 | Delta-like 4 mRNA is regulated by adjacent natural antisense transcripts |
| Q47156458 | Downregulation of the Long Non-Coding RNA Meg3 Promotes Angiogenesis After Ischemic Brain Injury by Activating Notch Signaling |
| Q37671796 | Endothelial signaling and the molecular basis of arteriovenous malformation |
| Q93030769 | Enhanced notch signaling modulates unproductive revascularization in response to nitric oxide-angiopoietin signaling in a mouse model of peripheral ischemia |
| Q96618200 | Evidence for endothelial-to-mesenchymal transition in human brain arteriovenous malformations |
| Q35169079 | Expression of the active Notch1 decreases MTC tumor growth in vivo. |
| Q36529825 | G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation |
| Q55183218 | Gene expression analysis of nidus of cerebral arteriovenous malformations reveals vascular structures with deficient differentiation and maturation. |
| Q35620061 | Gene expression profiling of blood in brain arteriovenous malformation patients |
| Q34824758 | Human brain arteriovenous malformations express lymphatic-associated genes |
| Q52148003 | Immunohistochemical Analysis of Sox17 Associated Pathway in Brain Arteriovenous Malformations. |
| Q92563157 | KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations |
| Q39691537 | Neuroglobin expression in human arteriovenous malformation and intracerebral hemorrhage |
| Q36861805 | Notch Signaling in the Vasculature |
| Q36602728 | Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas |
| Q35995125 | Notch receptor expression in human brain arteriovenous malformations |
| Q60300657 | Notch signaling pathway is a potential therapeutic target for extracranial vascular malformations |
| Q37561474 | Notch1 and 4 signaling responds to an increasing vascular wall shear stress in a rat model of arteriovenous malformations. |
| Q37425058 | Notch4 is activated in endothelial and smooth muscle cells in human brain arteriovenous malformations |
| Q41761841 | Notch4 normalization reduces blood vessel size in arteriovenous malformations |
| Q89553438 | Pathogenesis of non-hereditary brain arteriovenous malformation and therapeutic implications |
| Q39752032 | Signaling required for blood vessel maintenance: molecular basis and pathological manifestations |
| Q53083368 | Thalidomide-induced angiopoietin 2, Notch1 and Dll4 downregulation under hypoxic condition in tissues with gastrointestinal vascular malformation and human umbilical vein endothelial cells. |
| Q34081311 | The ARUBA trial: current status, future hopes |
| Q38268447 | VEGF, Notch and TGFβ/BMPs in regulation of sprouting angiogenesis and vascular patterning |
| Q36304260 | Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation |
Search more.